Finance ❯Stock Market ❯Investment Analysis
Visa Inc. Market Trends Target Stock Price Targets AMD Stock Performance Wedbush Securities Market Forecasts
AbbVie's emraclidine failed to meet key endpoints in Phase 2 trials, impacting its $8.7 billion acquisition of Cerevel Therapeutics.
